News
Class 4 Medicines Defect Information: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder and solvent for suspension for injection, EL (22)A/15
Source: MHRA / Gov.uk 17.3.22 Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack....
Company led medicines recall: Advanced Accelerator Applications NETSPOT (Kit for the preparation of gallium Ga 68 dotatate injection) [unlicensed medicine], CLMR (22)A/02
Source: MHRA / Gov.uk 16.3.22 Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during...
Dispex Education: FREE Training
Here at Dispex Education, we offer a wide variety of engaging and relevant online courses to meet the needs and requirements of all Dispensing Doctors’ staff, whether you are an...
Class 4 Medicines Defect Information, Ayrton Saunders Limited, Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries), EL (22)A/14
Source: MHRA/ Gov.uk 15.3.22 Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. MDR Number MDR 087-03/22 Company name Ayrton Saunders Limited Product description...
UK Covid-19 Inquiry
Source: UK Covid-19 Inquiry The independent public inquiry to examine the Covid-19 pandemic in the UK The UK Covid-19 Inquiry has been set up to examine the UK’s preparedness and...
Class 4 Medicines Defect Information: CNX Therapeutics Ltd, Latuda film-coated tablets, EL (22)A/13
Source: MHRA / Gov.uk 14.3.22 CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on...
Summer Tutorial Schedule 2022
We are pleased to announce our Summer schedule has been confirmed, and includes a brand new course subject; Medical Terminology, please click here for a course description. For the Summer...
NHS treats first sickle cell disease patients with life-changing drug
Source: NHS England NHS treats first sickle cell disease patients with life-changing drug Source: NHS England One of the first patients to access a ground-breaking treatment for sickle cell disease...
GPs most cost-effective and popular part of COVID-19 jab programme, says NAO
Source: GPOnline General practice delivered a far greater share of COVID-19 jabs than anticipated in the pandemic vaccination campaign – and at lower cost than other delivery models, according to...
Generics Costing More Than Tariff and Concessions – a Dispex Solution
Each month over 100 generics, as priced in the drug tariff or DM+D, are priced at a lower price than the purchase price. When you take the clawback into account,...
Have you seen the March Gazette?
This months’ highlights include: Hayfever formulary updates, new Summer training opportunities, bank change info and much more! Download your copy today! Want to receive the Gazette straight to your inbox?...
Class 4 Medicines Defect Information: Boots Company Plc, Decongestant Tablets and Decongestant with Pain Relief Tablets, EL (22)A/12
Source: MHRA / Gov.uk 10.3.22 Boots have identified an error with the printed patient information leaflet provided with batches of the Decongestant Tablets and Decongestant with Pain Relief Tablets. MDR...
